Core Viewpoint - GoHealth, Inc. has amended its credit agreement with lenders to provide covenant adjustments and extend the maturity of its revolving credit facility until September 30, 2025, aiming to strengthen its financial foundation and support future growth [1][2]. Group 1: Financial Adjustments - The amendment allows GoHealth to pursue receivables financing, including a securitization transaction, as part of a comprehensive financing plan to address its going concern position [1][2]. - The company has received broad-based support from stakeholders, enabling it to focus on long-term strategic priorities [2]. Group 2: Company Overview - GoHealth is a leading health insurance marketplace focused on Medicare, utilizing a technology platform that employs machine-learning algorithms to match health plans to consumer needs [3]. - The company has facilitated the enrollment of millions of consumers in Medicare plans since its inception, emphasizing its role in helping consumers navigate complex health insurance options [3].

GoHealth's Position and Opportunity - GoHealth aims to be an integrated "navigator" in the Medicare care journey, leveraging over 100 million interactions over the past decade[9] - GoHealth has evaluated over 10 million Medicare beneficiaries, providing insights into their needs[9] Industry Problem - Medicare Advantage (MA) plan enrollment has increased by 130% since 2009, leading to issues for beneficiaries and health plan partners[10] - Beneficiaries face being overwhelmed with information and a lack of trust in the process[12] Encompass Solution - GoHealth's Encompass solution is an end-to-end approach designed to simplify the Medicare experience[13] - Encompass Connect can deliver positive net cash in Year 1, with $260 cash in compared to the LTV model's -$350 cash out, and predictable, positive margins annually[16,17]

Financial Performance Highlights - GoHealth achieved record revenue of $877 million for FY 2020, representing a 63% increase year-over-year[7, 12] - Adjusted EBITDA for FY 2020 reached $271 million, a 59% increase compared to the previous year[7, 12] - The Adjusted EBITDA margin for FY 2020 was 31%[8, 12] - Q4 2020 revenue was $446 million, a 55% increase year-over-year[12] - Q4 2020 Adjusted EBITDA was $170 million, a 31% increase year-over-year, with a 38% margin[12, 27] Growth and Efficiency - Total submissions for FY 2020 were 730,000, a 71% increase year-over-year[6, 12] - Medicare-Internal segment revenue growth was 110% for FY 2020 and 75% for Q4 2020[12] - The company's commissions receivable balance grew by 112% to $810 million in 2020[29, 31] Outlook for 2021 - Projected revenue for FY 2021 is estimated to be between $1.15 billion and $1.3 billion, representing a growth of 31% to 48%[14] - Adjusted EBITDA for FY 2021 is projected to be between $345 million and $385 million, a growth of 27% to 42%[14] - The Adjusted EBITDA margin for FY 2021 is expected to be around 30%[14]

Core Viewpoint - Holzer & Holzer, LLC is investigating GoHealth, Inc. for potential violations of federal securities laws following a complaint from the Department of Justice alleging unlawful agreements and fraudulent claims [1] Group 1: Legal Investigation - The Department of Justice filed a complaint against GoHealth on May 1, 2025, alleging that the Company knowingly entered into unlawful agreements [1] - The complaint claims that GoHealth performed acts in furtherance of a conspiracy to present false or fraudulent claims to the Government [1] Group 2: Stock Impact - Following the news of the investigation, GoHealth's stock price experienced a decline [1] Group 3: Legal Representation - Holzer & Holzer, LLC is a law firm that specializes in representing shareholders and investors in litigation, including class action and derivative litigation [3] - The firm has a history of recovering hundreds of millions of dollars for shareholders affected by fraud and corporate misconduct since its founding in 2000 [3]

GoHealth (GOCO) Conference Summary Company Overview - GoHealth specializes in helping Medicare consumers navigate their insurance options, particularly Medicare Advantage plans, which are growing rapidly in the market [4][15] - The company has been in operation for over 20 years and has facilitated over 30 million shopping experiences for Medicare consumers [9] Core Business Model - GoHealth provides a personalized shopping experience for Medicare consumers, focusing on their specific healthcare needs, such as doctor networks and drug coverage [7][10] - The company operates primarily through a telephonic model, where 100% of enrollments occur via live conversations with licensed agents [14] Market Dynamics - The Medicare Advantage market is growing at a rate of 5-7% annually, with approximately 68 million consumers in Medicare, half of whom are enrolled in Medicare Advantage plans [15][16] - Over 11,000 new Medicare consumers enter the market daily, with a majority opting for Medicare Advantage plans [16] Competitive Advantage - GoHealth claims to have the lowest customer acquisition cost (CAC) in the industry, being 17% better than public peers and nearly 50% better than the industry average [37] - The company utilizes a proprietary Plan Fit tool that leverages data from 30 million shopping experiences to match consumers with the best insurance plans [33][40] Recent Challenges and Strategic Adjustments - The company has faced challenges due to health plans being tentative about growth under the current economic model, leading to a pullback in writing new Medicare Advantage business [46][47] - GoHealth is diversifying its offerings by introducing guaranteed acceptance life insurance to stabilize agent productivity during slower periods in the Medicare market [55][58] Financial Performance - GoHealth reported material improvements in revenue and adjusted EBITDA for Q1 2024 compared to Q1 2025, driven by efficient resource deployment and an acquisition [38] - The company is working on resetting covenants with lenders due to changes in its business model and market dynamics [49][53] Future Outlook - The upcoming Annual Enrollment Period (AEP) is expected to be highly disruptive, which could lead to increased demand for GoHealth's services as consumers seek new plans [66][68] - The company anticipates a significant increase in revenue from its life insurance business in Q2 and Q3 2025 [63] Key Differentiators - GoHealth emphasizes an unbiased shopping experience, ensuring that agents recommend the best plans for consumers, even if it means advising them to stay on their current plans [21][27] - The company focuses on building long-term relationships with consumers, expecting them to return for multiple shopping experiences throughout their Medicare tenure [30] Conclusion - GoHealth is positioned in a growing market with a unique business model that prioritizes consumer needs and leverages technology to enhance efficiency and customer experience [39][88]

Core Insights - Bragar Eagel & Squire, P.C. is investigating potential claims against GoHealth, Inc. and Abacus Global Management, Inc. for possible violations of federal securities laws and unlawful business practices [1] GoHealth, Inc. (NASDAQ:GOCO) - The U.S. Department of Justice filed a False Claims Act complaint against GoHealth and other health insurance companies, alleging that from 2016 to at least 2021, they paid hundreds of millions of dollars in illegal kickbacks to brokers for enrollments in Medicare Advantage plans [2] - Following the DOJ's announcement, GoHealth's stock price dropped by $1.09 per share, a decline of 10.35%, closing at $9.44 per share on May 1, 2025 [2] Abacus Global Management, Inc. (NASDAQ:ABL) - Morpheus Research published a report alleging that Abacus Global Management is involved in an accounting scheme related to life settlements, which artificially inflates revenue by underestimating mortality rates [3] - In response to the report, Abacus Global's stock price fell by more than 21% [3]

NEW YORK, May 30, 2025 /PRNewswire/ --Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of GoHealth, Inc. (NASDAQ: GOCO) resulting from allegations that GoHealth may have issued materially misleading business information to the investing public.So What: If you purchased GoHealth securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen ...

Core Viewpoint - GoHealth, Inc. is initiated with a Strong Buy rating and a price target of $20, highlighting its position as a leading digital Medicare and health insurance brokerage utilizing AI for plan optimization and consumer activation in the U.S. [1] Group 1: Company Overview - GoHealth operates in the digital Medicare and health insurance brokerage marketplace, leveraging AI technology to enhance plan optimization and consumer engagement [1]. - The company is positioned to benefit from the growing demand for digital health insurance solutions in the U.S. market [1]. Group 2: Research Methodology - Moretus Research employs a structured framework to identify companies with durable business models and mispriced cash flow potential, focusing on U.S. public markets [1]. - The research emphasizes rigorous fundamental analysis combined with a judgment-driven process, avoiding noise and overly complex forecasting [1]. - Valuation methods are based on sector-relevant multiples tailored to each company's business model, emphasizing comparability and relevance [1]. Group 3: Investment Philosophy - Moretus Research aims to identify underappreciated companies undergoing structural changes or temporary dislocations, where disciplined analysis can lead to asymmetric returns [1]. - The research reflects a commitment to capital discipline and long-term compounding, raising the standard for independent investment research [1].

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of GoHealth, Inc. due to allegations of materially misleading business information issued by the company [1]. Group 1: Legal Investigation and Class Action - Shareholders who purchased GoHealth securities may be entitled to compensation through a class action lawsuit without any out-of-pocket fees [2]. - The Rosen Law Firm is preparing a class action to seek recovery of investor losses related to GoHealth [2]. Group 2: Allegations and Stock Impact - The U.S. Department of Justice announced charges against GoHealth, alleging that from 2016 to 2021, the company was involved in illegal kickbacks totaling hundreds of millions of dollars to brokers for enrollments in Medicare Advantage plans [3]. - Following the announcement of these charges, GoHealth's stock price dropped by 10.3% on May 1, 2025, and an additional 6.7% on May 2, 2025 [3]. Group 3: Rosen Law Firm's Credentials - The Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company at the time [4]. - The firm has been ranked in the top 4 for securities class action settlements since 2013 and recovered over $438 million for investors in 2019 alone [4].

Core Viewpoint - Cohen Milstein Sellers & Toll PLLC is investigating GoHealth, Inc. for potential securities fraud related to a Medicare Advantage kickback scheme following a complaint from the Department of Justice [1][5]. Group 1: Investigation Details - The U.S. Department of Justice filed a False Claims Act complaint against GoHealth, alleging that from 2016 to at least 2021, the company and several insurers paid hundreds of millions of dollars in illegal kickbacks to brokers for enrollments in Medicare Advantage plans [5]. - Following the DOJ's lawsuit announcement, GoHealth's stock price dropped by $1.09 per share, or 10.35%, closing at $9.44 per share on May 1, 2025 [5]. Group 2: Investor Information - Investors who purchased shares of GoHealth between 2016 and May 1, 2025, are encouraged to contact Cohen Milstein for more information regarding the investigation [2]. - The law firm is actively seeking additional information and assistance related to the investigation [4]. Group 3: Law Firm Background - Cohen Milstein is recognized as one of the leading plaintiffs' law firms in the U.S., with a strong track record in securities litigation, having recovered billions for investors [7].